Announced
Completed
Synopsis
Equity investment by KKR Genetic Disorder in BridgeBio Pharma, a developer of precision medicinal therapies for the treatment of genetic pediatric diseases.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.